Microgrid controller Market: Global Industry Research Report 2020-2027 | Envisage Research

Microgrid controller Market - (By Connectivity, Grid Connected, Off Grid/Remote/Islanded)By Offering (Hardware, Software, Services) By Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 185

Status: Published

Report Code: EMR100562

The overall Microgrid controller market is expected to grow from USD 10 billion in 2020 to USD 19.8 billion by 2027, at a CAGR of 15.1% from 2020 to 2027. The growth of this market is being fueled by the rising demand for microgrids and increasing shift toward usage of renewable energy sources and reducing carbon footprint.

A microgrid is a localized group of interconnected loads and distributed energy resources that generally operate connected to and synchronous with the traditional microgrid. It can connect and disconnect from the grid to operate in grid-connected or island mode. The microgrid controller is a device that enables the formation of a microgrid by controlling the distribution of the energy resources and loads in a prearranged electrical system to provide acceptable frequency and voltage. The accelerating adoption of microgrid for reliable, & secure power supply, the fundamental shift towards the usage of renewable energy sources to reduce carbon footprint, increasing investment by governments on microgrid projects, and optimization of energy assets and enhanced efficiency of microgrids by using microgrid controllers are the major factors contributing to the growth of the global microgrid controller market.

In addition to this, modernization of infrastructure across the global to acquire smart city capabilities is leading to an increase in the demand for microgrids, which in turn, is strengthening the demand for microgrid controllers in the coming years. The strong demand for microgrid from the utility, government, and military sector across the globe, rising emphasis on the development of smart cities, especially in the developing economies, followed by the growing necessity to upgrade the existing old grid infrastructure will create innumerable growth opportunities for the market.

However, on the other hand, the high cost of microgrids and the implementation of stringent government regulations are some factors that will hamper the growth of the market.

Major vendors in the global microgrid controller market are Schneider Electric (France), General Electric (US), ABB (Switzerland), Siemens (Germany), Schweitzer Engineering Laboratories (US), Eaton Corporation (Ireland), Honeywell International (US), Lockheed Martin (US), S&C Electric (US), and Power Analytics (US).

Analyst Commentary

The growth of this market is being fuelled by the rising demand for microgrids and increasing shift toward usage of renewable energy sources and reducing carbon footprint.

Based on the connectivity, the grid-connected is expected to grow at a higher CAGR during the forecast period owing to its ability to provide higher reliability as compared to the remote/off-grid/islanded grid. In a grid-connected microgrid, power transmission depends on the primary grid, while isolated microgrids produce their own power without any connection with the utility grid.

Based on offering, the software segment is projected to grow at a higher CAGR during the forecast period due to its ability to monitor, predict, handle, and maximize the energy supply. The hardware segment is expected to lead the market during the forecast period owing to its high price components such as HMIs, intelligent controllers, and generation optimizer.

In April 2019, ABB entered into a productive partnership with Rolls Royce to provide innovative and energy-efficient solutions for commercial, industrial, and utility sector. The partnership will bring forth the combination of Rolls Royce’s MTU Diesel and ABB’s modular microgrid solution and offer more renewable energy with reduced carbon footprints.

In November 2018, GE Power Digital announced a joint venture with PPL Electric Utilities to facilitate the adoption of energy generation while focusing on grid safety and its reliability. As per the agreement, PPL will employ GE’s DER Orchestration and incorporate it with Advanced Distribution Management Solutions to model and enhance the grid operations, load forecasting, and maintain grid reliability.

Segmentation

The global market is segmented based on offering , connectivity and region. On the basis of offering the market is segmented into hardware, software, and services. Based on connectivity the market is segmented into Grid Connected, Off Grid/Remote/Islanded.

Regional Analysis

The global market for microgrid controller is estimated to grow at a significant rate during the forecast period from 2019 to 2025. The geographical analysis of the market is done for North America, Europe, Asia-Pacific, and the rest of the world.

North America followed by Europe is expected to dominate the microgrid controller market from 2019 to 2025 owing to the government initiatives that have encouraged the microgrid installations in the region. Furthermore, high concentration of market players in the region and availability of proficient technical expertise propel the demand for microgrid controller in the region.

Based on the region, the Asia-pacific region is projected to grow at a higher CAGR in the global Microgrid Controller market over the forecast period. The continuous expansion in the industrial sector and the development of power infrastructure, especially in China, Japan, and India, are boosting the growth of the market in this region. Asia-pacific is one of the potential markets for microgrid controller systems. The electricity demand in the Asia-pacific is increasing faster than the expansion of traditional electricity grids, which further fuels the growth of the market.

TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Engine Powered of Suppliers
3.7.2. Bargaining Engine Powered of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Leukaemia Therapeutics Market
Chapter 5. Global Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
5.1. Global Leukaemia Therapeutics Market Share, By Types of leukaemia, 2015 - 2027 (USD Billion)
5.1.1. Acute lymphocytic leukemia (ALL)
5.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Chronic lymphocytic leukemia (CLL)
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Acute myeloid leukemia (AML)
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Others
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Billion)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Leukaemia Therapeutics Market Overview, By Mode of Administration, 2015 - 2027 (USD Billion)
6.1. Global Leukaemia Therapeutics Market Share, By Mode of Administration, 2015 - 2027 (USD Billion)
6.1.1. Injectable
6.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. ORAL
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
7.1. Global Leukaemia Therapeutics Market Share, By Gender, 2015 - 2027 (USD Billion)
7.1.1. Male
7.1.1.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Female
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Leukaemia Therapeutics Market Overview, By Geography, 2015 - 2027 (USD Billion)
8.1. Global Leukaemia Therapeutics Market Share, By Geography, 2015 - 2027 (USD Billion)
8.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 & 2027 (%)
Chapter 9. North America Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1. North America Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
9.1.3. North America Leukaemia Therapeutics Market Overview, By Mode of Administration, 2015 - 2027 (USD Billion)
9.1.4. North America Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
9.1.5. North America Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
9.1.5.1.3. Other Segments
9.1.5.2. Canada Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
9.1.5.2.3. Other Segments
9.1.5.3. Mexico Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
9.1.5.3.3. Other Segments
Chapter 10. Europe Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1. Europe Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.3. Europe Leukaemia Therapeutics Market Overview, By Mode of Administration, 2015 - 2027 (USD Billion)
10.1.4. Europe Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
10.1.5. Europe Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.5.1.3. Others Segments
10.1.5.2. France
10.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. France Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.5.2.3. Others Segments
10.1.5.3. UK
10.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. UK Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.5.3.3. Others Segments
10.1.5.4. Italy
10.1.5.4.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Italy Leukaemia Therapeutics Market Overview, By Types of leukaemia 2015 - 2027 (USD Billion)
10.1.5.4.3. Others Segments
10.1.5.5. Spain
10.1.5.5.1. Market size and projections, 2015 - 2027 (USD Billion)
10.1.5.5.2. Spain Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.5.5.3. Others Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market size and projections, 2015 – 2025
10.1.5.6.2. Rest of Europe Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
10.1.5.6.3. Others Segments
Chapter 11. Asia Pacific Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Asia Pacific Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.2. Asia Pacific Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.3. Asia Pacific Leukaemia Therapeutics Market Overview, By Mode of Administration, 2015 - 2027 (USD Billion)
11.1.4. Asia Pacific Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
11.1.5. Asia Pacific Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.5.1. India
11.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.5.1.2. India Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.5.1.3. Other Segments
11.1.5.2. China
11.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.5.2.2. China Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.5.2.3. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.5.3.2. Japan Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.5.3.3. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.5.4.2. South Korea Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.5.4.3. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market size and projections, 2015 - 2027 (USD Billion)
11.1.5.5.2. Rest of Asia Pacific Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
11.1.5.5.3. Other Segments
Chapter 12. Middle East & Africa Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Middle East & Africa Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.2. Middle East & Africa Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
12.1.3. Middle East & Africa Leukaemia Therapeutics Market Overview, By Mode of Administration, 2015 - 2027 (USD Billion)
12.1.4. Middle East & Africa Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
12.1.5. Middle East & Africa Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.5.1.2. GCC Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
12.1.5.1.3. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.5.2.2. South Africa Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
12.1.5.2.3. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market size and projections, 2015 - 2027 (USD Billion)
12.1.5.3.2. Rest of Middle East & Africa Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
12.1.5.3.3. Other Segments
Chapter 13. South America Leukaemia Therapeutics Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. South America Leukaemia Therapeutics Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.2. South America Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
13.1.3. South America Leukaemia Therapeutics Market Overview, By Gender, 2015 - 2027 (USD Billion)
13.1.4. South America Leukaemia Therapeutics Market Overview, By Countries, 2015- 2026 (USD Billion)
13.1.5. Brazil
13.1.5.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.5.2. Brazil Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
13.1.5.3. Other Segments
13.1.6. Argentina
13.1.6.1. Market size and projections, 2015 - 2027 (USD Billion)
13.1.6.2. Argentina Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
13.1.6.3. Other Segments
13.1.7. Rest of South America
13.1.7.1. Market size and projections, 2015 – 2027
13.1.7.2. Rest of South America Leukaemia Therapeutics Market Overview, By Types of leukaemia, 2015 - 2027 (USD Billion)
13.1.7.3. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Distribution channel development
Chapter 15. Key Vendor Analysis
15.1. AbbVie.
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Distribution channel Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Bristol-Myers Squibb
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Distribution channel Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Novartis
15.4. F. Hoffmann-La Roche
15.5. Gilead Sciences
15.6. Sanofi
15.7. Amgen
15.8. Gilead Sciences
15.9. Takeda Pharmaceutical
15.10. Celgene
Chapter 16. Leukaemia Therapeutics Market Cost Analysis
16.1. Leukaemia Therapeutics Market Key Raw Material Analysis
16.1.1. Key Raw Material
16.1.2. Price Trend of Key Raw Material
16.1.3. Key Suppliers of Raw Material
16.1.4. Market Concentration Rate of Raw Material
Chapter 17. Industrial Chain, Sourcing Strategy and Downstream Buyers
17.1. Leukaemia Therapeutics Market Industrial Chain Analysis
17.2. Upstream Raw Material Sourcing
17.3. Raw Material Source of Leukaemia Therapeutics Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Oral
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Distribution channel
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Engine Powered of Suppliers
5. Engine Powered of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Leukaemia Therapeutics Market share, By Types of leukaemia, 2020 & 2027 (%)
10. Global Leukaemia Therapeutics Market share, by Acute lymphocytic leukemia (ALL), By Types of leukaemia, 2020 & 2027 (USD Billion)
11. Global Leukaemia Therapeutics Market share, by Chronic lymphocytic leukemia (CLL) (AML), By Types of leukaemia, 2020 & 2027 (USD Billion)
12. Global Leukaemia Therapeutics Market share, by Acute myeloid leukemia (AML), By Types of leukaemia, 2020 & 2027 (USD Billion)
13. Global Leukaemia Therapeutics Market share, by Others, By Types of leukaemia, 2020 & 2027 (USD Billion)
14. Global Leukaemia Therapeutics Market share, By Mode of Administration, 2020 & 2027 (%)
15. Global Leukaemia Therapeutics Market share, by ORAL, By Mode of Administration, 2020 & 2027 (USD Billion)
16. Global Leukaemia Therapeutics Market share, by Injectable, By Mode of Administration, 2020 & 2027 (USD Billion)
17. Global Leukaemia Therapeutics Market share, by Region, 2020 & 2027 (%)
18. Global Leukaemia Therapeutics Market share, by region, 2020 - 2027(USD Billion)
19. North America Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
20. North America Leukaemia Therapeutics Market share, by Countries, 2020 & 2027 (%)
21. U.S. Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
22. Canada Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
23. Europe Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
24. Europe Leukaemia Therapeutics Market share, by Countries, 2020 & 2027 (%)
25. Spain Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
26. UK Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
27. Italy Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
28. Germany Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
29. France Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
30. Rest of Europe Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
31. Asia-Pacific Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
32. Asia-Pacific Leukaemia Therapeutics Market share, by Countries, 2020 & 2027 (%)
33. China Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
34. India Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
35. Australia Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
36. Japan Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
37. Rest of Asia-Pacific Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
38. Middle East & Africa Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
39. Middle East & Africa Leukaemia Therapeutics Market share, by Countries, 2020 & 2027 (%)
40. GCC Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
41. South Africa Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
42. Rest Of Middle East & Africa Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
43. South America Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
44. Brazil Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
45. Mexico Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
46. Argentina Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)
47. Rest Of South America Leukaemia Therapeutics Market, 2020 - 2027(USD Billion)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global Leukaemia Therapeutics Market, 2020-2027 (USD Billion)
4. Leukaemia Therapeutics requirement, by country, 2020-2027, (USD Billion)
5. North America Leukaemia Therapeutics Market, By Types of leukaemia, 2020-2027 (USD Billion)
6. North America Leukaemia Therapeutics Market, By Mode of Administration, 2020-2027 (USD Billion)
7. Europe Leukaemia Therapeutics Market, By Types of leukaemia, 2020-2027 (USD Billion)
8. Europe Leukaemia Therapeutics Market, By Mode of Administration, 2020-2027 (USD Billion)
9. Asia Pacific Leukaemia Therapeutics Market, By Types of leukaemia, 2020-2027 (USD Billion)
10. Asia Pacific Leukaemia Therapeutics Market, By Mode of Administration, 2020-2027 (USD Billion)
11. Middle East & Africa Leukaemia Therapeutics Market, By Types of leukaemia, 2020-2027 (USD Billion)
12. Middle East & Africa Leukaemia Therapeutics Market, By Mode of Administration, 2020-2027 (USD Billion)
13. South America Leukaemia Therapeutics Market, By Types of leukaemia, 2020-2027 (USD Billion)
14. South America Leukaemia Therapeutics Market, By Mode of Administration, 2020-2027 (USD Billion)
15. Global Leukaemia Therapeutics Market, Company Market Share, 2020 & 2027(%)
16. AbbVie : Product Benchmarking
17. AbbVie : Financial Performance
18. Bristol-Myers Squibb : Product Benchmarking
19. Bristol-Myers Squibb : Financial Performance
20. Novartis : Product Benchmarking
21. Novartis : Financial Performance
22. F. Hoffmann-La Roche : Product Benchmarking
23. F. Hoffmann-La Roche : Financial Performance
24. Pfizer : Product Benchmarking
25. Pfizer : Financial Performance
26. Sanofi: Product Benchmarking
27. Sanofi: Financial Performance
28. Amgen : Product Benchmarking
29. Amgen : Financial Performance
30. Gilead Sciences : Product Benchmarking
31. Gilead Sciences : Financial Performance
32. Takeda Pharmaceutical : Product Benchmarking
33. Takeda Pharmaceutical : Financial Performance
34. Celgene : Product Benchmarking
35. Celgene : Financial Performance

The Leading Key Players in Microgrid Controller Market

Schneider Electric (France)
General Electric (US)
ABB (Switzerland)
Siemens (Germany)
Schweitzer Engineering Laboratories (US)
Eaton Corporation (Ireland)
Honeywell International (US)
Lockheed Martin (US)
S&C Electric (US)
Power Analytics (US).